Georgia Medical Cannabis Workplace Protection — None

Georgia is an at-will employment state with no statewide protections for medical cannabis patients. HB 1 / Haleigh’s Hope Act explicitly states an employer is "not required to permit or accommodate the use, consumption, or possession of marijuana in any form." The state Drug-Free Workplace Act offers a 7.5% workers’-compensation premium discount — a financial incentive to test. Federal contractors apply zero-tolerance under the federal Drug-Free Workplace Act of 1988.

Last verified: May 2026

Georgia Is At-Will Employment

Georgia is an at-will employment state with no statutory protection for off-duty cannabis use. Unlike Connecticut, New York, California (since 2024), and several other states that have enacted off-duty-use protections, Georgia law does not bar employer discrimination based on a positive cannabis test.

The HB 1 Explicit Carve-Out

Haleigh’s Hope Act expressly states an employer is "not required to permit or accommodate the use, consumption, or possession of marijuana in any form." The carve-out preempts any argument that the medical-cannabis program created an implicit accommodation duty under Georgia disability or employment law. A registered patient can be terminated for failed drug screens regardless of cardholder status.

The State Drug-Free Workplace Act

Under O.C.G.A. § 34-9-410 et seq., employers who maintain certified drug-free workplaces receive workers’ compensation premium discounts of up to 7.5%. This creates a meaningful financial incentive to test:

  • Pre-employment drug tests.
  • Reasonable-suspicion testing.
  • Post-accident testing.
  • Random testing for safety-sensitive roles.

The 7.5% workers’-comp discount is meaningful enough that participating employers represent a substantial fraction of Georgia’s mid-size and large employers.

Federal Contractors and the Drug-Free Workplace Act of 1988

Many large Georgia employers — defense contractors, financial firms with federal exposure, healthcare systems with Medicare/Medicaid participation, and federal grant recipients — operate under the Federal Drug-Free Workplace Act of 1988. These employers apply zero-tolerance policies regardless of state law. The state medical-cannabis card is no defense.

Federal-Installation Personnel

For Fort Stewart / Hunter Army Airfield, Fort Eisenhower (with NSA Georgia + U.S. Army Cyber Command), Fort Benning, Robins AFB, Moody AFB, Naval Submarine Base Kings Bay, and CDC Atlanta personnel, federal drug-testing applies. Cannabis use of any form (including medical-card use) is grounds for termination, security-clearance revocation, and — for active-duty service members — court-martial under UCMJ Article 112a. See federal-installations page.

The DOT-Regulated Workforce

DOT-regulated transportation employees — commercial drivers, FAA-regulated aviation personnel, FRA-regulated rail workers, USCG-regulated maritime workers, FTA-regulated transit workers — are subject to federal DOT testing rules with zero tolerance for any THC, with no medical-card defense. Major Georgia employers in this category include:

  • Delta Air Lines (Atlanta HQ, ~33,000 metro employees) — DOT-regulated for safety-sensitive positions including pilots, flight attendants, mechanics.
  • UPS (Atlanta HQ, ~6,000 metro employees) — DOT-regulated drivers.
  • Norfolk Southern — FRA-regulated rail.

Hartsfield-Jackson Atlanta International Airport

The world’s busiest passenger airport employs ~63,000+ workers across airlines, ground handlers, TSA, FAA, food service, and contractors. TSA-screened employees and FAA-regulated personnel face zero-tolerance federal drug-testing. Cannabis (medical-card or not) found at TSA may be referred to local law enforcement at the airport’s discretion.

The Practical Result

A registered Georgia low-THC oil cardholder who:

  • Lawfully purchased product from a licensed dispensary or partner pharmacy.
  • Lawfully consumed it off-duty in private.
  • Returned to work the next day with no active impairment.
  • Tested positive for inactive THC metabolites in a workplace drug screen.

...has no employment protection against termination, refusal-to-hire, or denial of workers’ compensation. The card provides essentially zero defense in safety-sensitive, federal-contract, federal-employment, or DOT-regulated employment contexts.

Comparison with Other States

  • California (AB 2188, eff. Jan 2024) — bars employer discrimination based on off-duty cannabis use, with safety-sensitive carve-outs.
  • Connecticut (Public Act 21-1) — off-duty protection.
  • New York, New Jersey, Massachusetts, Nevada, Rhode Island — varying levels of off-duty protection.
  • Georgia — no protection at all.

Georgia patients should not expect their card to provide meaningful workplace protection. The federal-employer footprint in Georgia is enormous (CDC, Fort Stewart, Fort Eisenhower, Fort Benning, Robins, Moody, Kings Bay, Hartsfield-Jackson) and federal drug-testing reaches deep into the white-collar and blue-collar workforce.

SB 220 (2026) Workplace Implications

SB 220, if signed by Gov. Kemp by ~May 12, 2026, does not change the workplace-protection framework. The HB 1 explicit carve-out persists; employers retain the right to maintain drug-free workplace policies and to test. SB 220’s expansion is to medical-cannabis access — not employment protections.